Literature DB >> 26393141

Role of Cytochrome Modulators in Altering the Occurrence of Cataract in Rats.

Kanchan Gupta1, Shivani Juneja2, G S Bajwa3, Sandeep Kaushal4.   

Abstract

BACKGROUND: Cataract is one of the primary causes of blindness all over the world. It indicates the onset of secondary complications of diabetes. The only treatment available is surgery as there are no satisfactory drugs which can prevent or retard the initiation and maturation of cataract. It was hypothesized that cytochrome P 450 (CYP) inducers or inhibitors can modify the cataract occurrence by accelerating or delaying the occurrence of cataract respectively.
OBJECTIVE: To study the effect of two commonly used drugs, phenytoin (CYP inducer) and ciprofloxacin (CYP inhibitor) on the initiation and maturation of cataract with the galactose- induced cataract model.
MATERIALS AND METHODS: The experiment was conducted in 24 new born male Wistar rats. Cataract formation was induced with a 50% galactose diet. The rats were randomized into four groups of 6 rats each: Group 1 rats received a normal diet; Group 2, 3 and 4 rats received 50% galactose diet day 23 onwards. In addition, Group 3 rats were pre-treated with ciprofloxacin (20mg/kg) and Group 4 rats were pre-treated with phenytoin (50mg/kg) day 18 onwards once a day orally. The appearance of cataract was checked daily with an ophthalmoscope. The maturation pattern was examined using Fundus Fluorsen Angiographer (FFA). The cataract was graded according to Sippel's classification. The experimental and control groups were compared by chi square test and the results were considered significant at p< 0.05.
RESULTS: The initiation of cataract was significantly delayed with ciprofloxacin as compared to galactose; however, there was no difference in the maturation pattern of cataract in both the groups. In spite of being a CYP inducer, the initiation of cataract was not accelerated in phenytoin group. Rather, it was significantly delayed and the cataract did not progress to stage 5 even on 30(th) day of galactose administration.
CONCLUSION: CYP450 modulators have a significant effect on the initiation of cataract without significantly altering the maturation pattern. It is not reasonable to extrapolate the results of one enzyme inhibitor or inducer to other CYP modulators. Hence, further studies are needed to identify the pharmacological profile of various CYP modulators on the occurrence of cataractogenesis.

Entities:  

Keywords:  Galactose; Microsomal enzyme inducer; Microsomal enzyme inhibitor

Year:  2015        PMID: 26393141      PMCID: PMC4572972          DOI: 10.7860/JCDR/2015/12411.6216

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  Correlation between adult diabetic cataracts and red blood cell aldose reductase levels.

Authors:  Namiki Oishi; Soichi Morikubo; Yoshihiro Takamura; Eri Kubo; Shosai Tsuzuki; Tsuyoshi Tanimoto; Yoshio Akagi
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

Review 2.  Potential use of aldose reductase inhibitors to prevent diabetic complications.

Authors:  G J Zenon; C V Abobo; B L Carter; D W Ball
Journal:  Clin Pharm       Date:  1990-06

3.  Effects of novel hydantoin derivatives with aldose reductase inhibiting activity on galactose-induced cataract in rats.

Authors:  K Kato; K Nakayama; M Ohta; N Murakami; K Murakami; M Mizota; I Miwa; J Okuda
Journal:  Jpn J Pharmacol       Date:  1990-12

4.  Aldose reductase inhibitors and prevention of galactose cataracts in rats.

Authors:  N Unakar; J Tsui; M Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-07       Impact factor: 4.799

5.  Diabetic cataract-pathogenesis, epidemiology and treatment.

Authors:  Andreas Pollreisz; Ursula Schmidt-Erfurth
Journal:  J Ophthalmol       Date:  2010-06-17       Impact factor: 1.909

6.  Influence of galactose cataract on erythrocytic and lenticular glutathione metabolism in albino rats.

Authors:  M Jyothi; R Sanil; S Shashidhar
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

7.  How to calculate sample size in animal studies?

Authors:  Jaykaran Charan; N D Kantharia
Journal:  J Pharmacol Pharmacother       Date:  2013-10

8.  Effect of rifampicin and erythromycin on the initiation of galactose induced cataract in rats.

Authors:  Raj Rajeshwari R Patil; Pratibha S Worlikar; Amol B Chaudhari; Ozhukil K Radhakrishnan; Rajendra P Gupta; Saurabh Puri
Journal:  J Pharmacol Pharmacother       Date:  2012-10

Review 9.  Advances in pharmacological strategies for the prevention of cataract development.

Authors:  S K Gupta; V Kalai Selvan; S S Agrawal; Rohit Saxena
Journal:  Indian J Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.848

Review 10.  The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.

Authors:  Mara Lorenzi
Journal:  Exp Diabetes Res       Date:  2007
View more
  1 in total

1.  Long non-coding RNA ANRIL alleviates H2O2-induced injury by up-regulating microRNA-21 in human lens epithelial cells.

Authors:  Shanshan Du; Jingzhi Shao; Ying Qi; Xuhui Liu; Jingjing Liu; Fengyan Zhang
Journal:  Aging (Albany NY)       Date:  2020-04-20       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.